We are live on ! Find out more
ZGNX

Zogenix, Inc.

Delisted

ZGNX was delisted on the 4th of March, 2022.

161 hedge funds and large institutions have $1.78B invested in Zogenix, Inc. in 2018 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 46 increasing their positions, 69 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

309% more call options, than puts

Call options by funds: $39.6M | Put options by funds: $9.7M

0% more funds holding in top 10

Funds holding in top 10: 1111 (0)

5% less funds holding

Funds holding: 170161 (-9)

23% less capital invested

Capital invested by funds: $2.31B → $1.78B (-$523M)

32% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 28

33% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 69

Holders
161
Holders Change
-9
Holders Change %
-5.29%
% of All Funds
3.59%
Holding in Top 10
11
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.25%
New
19
Increased
46
Reduced
69
Closed
28
Calls
$39.6M
Puts
$9.7M
Net Calls
+$29.9M
Net Calls Change
-$21.4M
Name Holding Trade Value Shares
Change
Change in
Stake
FI
76
Fosun International
China
$1.61M +$1.87M +45,700 New
State of Wisconsin Investment Board
77
State of Wisconsin Investment Board
Wisconsin
$1.57M -$12.3K -300 -0.7%
New York State Common Retirement Fund
78
New York State Common Retirement Fund
New York
$1.54M -$164K -4,000 -9%
ACM
79
Atika Capital Management
New York
$1.46M -$450K -11,000 -22%
Hudson Bay Capital Management
80
Hudson Bay Capital Management
Connecticut
$1.46M +$1.64M +40,000 New
Wells Fargo
81
Wells Fargo
California
$1.42M +$141K +3,438 +10%
EAM
82
Erste Asset Management
Austria
$1.41M +$1.63M +39,900 New
CCM
83
Cohen Capital Management
California
$1.31M +$22.1K +540 +2%
SG Americas Securities
84
SG Americas Securities
New York
$1.21M +$1.27M +30,981 +1,415%
MCM
85
Moore Capital Management
New York
$1.09M
PAI
86
Palo Alto Investors
California
$1.08M
AIG
87
American International Group
New York
$1.01M -$8.68K -212 -0.8%
DMK
88
David M. Knott
$949K
GS
89
Gagnon Securities
New York
$948K -$40.6K -991 -4%
UBS AM
90
UBS AM
Illinois
$946K +$363K +8,866 +52%
Manulife (Manufacturers Life Insurance)
91
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$929K -$65K -1,587 -6%
TAM
92
Tiverton Asset Management
Delaware
$866K -$5.77K -141 -0.6%
State Board of Administration of Florida Retirement System
93
State Board of Administration of Florida Retirement System
Florida
$766K +$38.2K +933 +5%
First Trust Advisors
94
First Trust Advisors
Illinois
$757K -$212K -5,175 -20%
MIM
95
MetLife Investment Management
New Jersey
$708K
EGI
96
EAM Global Investors
California
$702K -$271K -6,627 -26%
ProShare Advisors
97
ProShare Advisors
Maryland
$680K -$145K -3,548 -16%
Squarepoint
98
Squarepoint
New York
$640K +$134K +3,273 +23%
Barclays
99
Barclays
United Kingdom
$635K -$869K -21,218 -55%
Creative Planning
100
Creative Planning
Kansas
$613K

ZGNX Hedge Fund Activity: Q4 2018 in Review

161 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Zogenix, Inc. (ZGNX) for Q4 2018, worth a combined $1.78B — down 23% from $2.31B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of ZGNX and 19 opened new positions — a net loss of 9 holders — while 69 trimmed existing stakes and 46 added.

The largest buyer was Fidelity Investments, adding an estimated $119M. The largest seller was Scopia Capital Management, cutting an estimated $95M.

  • 161 institutional investors held Zogenix, Inc. (ZGNX) as of Q4 2018, down from 170 in Q3 2018.
  • Funds reported $1.78B of Zogenix, Inc. stock for Q4 2018, down 23% quarter-over-quarter.
  • 19 funds opened new Zogenix, Inc. positions in Q4 2018 and 28 closed out, a net change of -9 holders.
  • The largest Zogenix, Inc. buyer in Q4 2018 was Fidelity Investments, an estimated $119M added.
  • The largest Zogenix, Inc. seller in Q4 2018 was Scopia Capital Management, an estimated $95M sold.

Based on aggregated 13F filings for Q4 2018.